日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia

对于无症状的低危慢性淋巴细胞白血病患者,停止专门的随访是可行且安全的。

Brieghel, Christian; da Cunha-Bang, Caspar; Mourek, Jindrich; Kjeldsen, Lars; Niemann, Carsten U

Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases

p90 核糖体 S6 激酶 C 末端激酶结构域的激活和抑制

Marlene Uglebjerg Fruergaard, Christine Juul Fælled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen

Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial

60至70岁接受减低强度移植治疗急性髓系白血病老年患者的预后:NCRI急性髓系白血病16试验结果

Russell, Nigel H; Hills, Robert K; Thomas, Abin; Thomas, Ian; Kjeldsen, Lars; Dennis, Mike; Craddock, Charles; Freeman, Sylvie; Clark, Richard E; Burnett, Alan K

Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study

为新确诊血液肿瘤患者的照护者提供家庭照护者大使支持:一项可行性研究

Husted Nielsen, Iben; Piil, Karin; Tolver, Anders; Grønbæk, Kirsten; Kjeldsen, Lars; Jarden, Mary

Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

确定年轻急性髓系白血病患者最佳化疗疗程总数:三个疗程与四个疗程的比较

Burnett, Alan K; Russell, Nigel H; Hills, Robert K; Knapper, Stephen; Freeman, Sylvie; Huntly, Brian; Clark, Richard E; Thomas, Ian F; Kjeldsen, Lars; McMullin, Mary Frances; Drummond, Mark; Kell, Jonathan; Spearing, Ruth

Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study

患者大使在急性白血病新诊断患者治疗期间的支持:一项可行性研究

Nørskov, Kristina Holmegaard; Overgaard, Dorthe; Boesen, Jannie; Struer, Anne; El-Azem, Sarah Elke Weber Due; Tolver, Anders; Lomborg, Kirsten; Kjeldsen, Lars; Jarden, Mary

Patient ambassador support: Experiences of the mentorship between newly diagnosed patients with acute leukaemia and their patient ambassadors

患者大使支持:新确诊急性白血病患者与其患者大使之间的指导经验

Nørskov, Kristina Holmegaard; Overgaard, Dorthe; Lomborg, Kirsten; Kjeldsen, Lars; Jarden, Mary

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial

在急性髓系白血病巩固治疗中加入哺乳动物雷帕霉素靶蛋白抑制剂依维莫司:来自英国NCRI AML17试验的经验

Burnett, Alan K; Das Gupta, Emma; Knapper, Steve; Khwaja, Asim; Sweeney, Marion; Kjeldsen, Lars; Hawkins, Timothy; Betteridge, Sophie E; Cahalin, Paul; Clark, Richard E; Hills, Robert K; Russell, Nigel H

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

在接受端粒相关疾病基因检测的北欧患者中发现的新变异

Norberg, Anna; Rosén, Anna; Raaschou-Jensen, Klas; Kjeldsen, Lars; Moilanen, Jukka S; Paulsson-Karlsson, Ylva; Baliakas, Panagiotis; Lohi, Olli; Ahmed, Aymen; Kittang, Astrid O; Larsson, Pär; Roos, Göran; Degerman, Sofie; Hultdin, Magnus

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.

一项随机评估在 FLT3 突变型 AML 的一线化疗中加入激酶抑制剂 lestaurtinib 的疗效

Knapper Steven, Russell Nigel, Gilkes Amanda, Hills Robert K, Gale Rosemary E, Cavenagh James D, Jones Gail, Kjeldsen Lars, Grunwald Michael R, Thomas Ian, Konig Heiko, Levis Mark J, Burnett Alan K